Global Pharmaceutical Regulatory Affairs Market Size, Status and Forecast 2021-2027

Global Pharmaceutical Regulatory Affairs Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Regulatory Affairs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Regulatory Consulting
1.2.3 Legal Representation
1.2.4 Regulatory Writing & Publishing
1.2.5 Product Registration & Clinical Trial Application
1.2.6 Other Services
1.3 Market by Application
1.3.1 Global Pharmaceutical Regulatory Affairs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 In-house
1.3.3 Outsourcing
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Regulatory Affairs Market Perspective (2016-2027)
2.2 Pharmaceutical Regulatory Affairs Growth Trends by Regions
2.2.1 Pharmaceutical Regulatory Affairs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutical Regulatory Affairs Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutical Regulatory Affairs Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutical Regulatory Affairs Industry Dynamic
2.3.1 Pharmaceutical Regulatory Affairs Market Trends
2.3.2 Pharmaceutical Regulatory Affairs Market Drivers
2.3.3 Pharmaceutical Regulatory Affairs Market Challenges
2.3.4 Pharmaceutical Regulatory Affairs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Regulatory Affairs Players by Revenue
3.1.1 Global Top Pharmaceutical Regulatory Affairs Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutical Regulatory Affairs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Regulatory Affairs Revenue
3.4 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio
3.4.1 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Regulatory Affairs Revenue in 2020
3.5 Pharmaceutical Regulatory Affairs Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Regulatory Affairs Product Solution and Service
3.7 Date of Enter into Pharmaceutical Regulatory Affairs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Regulatory Affairs Breakdown Data by Type
4.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Type (2022-2027)
5 Pharmaceutical Regulatory Affairs Breakdown Data by Application
5.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmaceutical Regulatory Affairs Market Size (2016-2027)
6.2 North America Pharmaceutical Regulatory Affairs Market Size by Type
6.2.1 North America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
6.3 North America Pharmaceutical Regulatory Affairs Market Size by Application
6.3.1 North America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
6.4 North America Pharmaceutical Regulatory Affairs Market Size by Country
6.4.1 North America Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharmaceutical Regulatory Affairs Market Size (2016-2027)
7.2 Europe Pharmaceutical Regulatory Affairs Market Size by Type
7.2.1 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
7.3 Europe Pharmaceutical Regulatory Affairs Market Size by Application
7.3.1 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
7.4 Europe Pharmaceutical Regulatory Affairs Market Size by Country
7.4.1 Europe Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceutical Regulatory Affairs Market Size (2016-2027)
9.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Type
9.2.1 Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutical Regulatory Affairs Market Size by Application
9.3.1 Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutical Regulatory Affairs Market Size by Country
9.4.1 Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 QuintilesIMS
11.1.1 QuintilesIMS Company Details
11.1.2 QuintilesIMS Business Overview
11.1.3 QuintilesIMS Pharmaceutical Regulatory Affairs Introduction
11.1.4 QuintilesIMS Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.1.5 QuintilesIMS Recent Development
11.2 LabCor
11.2.1 LabCor Company Details
11.2.2 LabCor Business Overview
11.2.3 LabCor Pharmaceutical Regulatory Affairs Introduction
11.2.4 LabCor Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.2.5 LabCor Recent Development
11.3 PAREXEL
11.3.1 PAREXEL Company Details
11.3.2 PAREXEL Business Overview
11.3.3 PAREXEL Pharmaceutical Regulatory Affairs Introduction
11.3.4 PAREXEL Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.3.5 PAREXEL Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Details
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Introduction
11.4.4 Pharmaceutical Product Development Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 INC RESEARCH HOLDINGS
11.5.1 INC RESEARCH HOLDINGS Company Details
11.5.2 INC RESEARCH HOLDINGS Business Overview
11.5.3 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Introduction
11.5.4 INC RESEARCH HOLDINGS Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.5.5 INC RESEARCH HOLDINGS Recent Development
11.6 PRA Health Sciences
11.6.1 PRA Health Sciences Company Details
11.6.2 PRA Health Sciences Business Overview
11.6.3 PRA Health Sciences Pharmaceutical Regulatory Affairs Introduction
11.6.4 PRA Health Sciences Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.6.5 PRA Health Sciences Recent Development
11.7 ICON
11.7.1 ICON Company Details
11.7.2 ICON Business Overview
11.7.3 ICON Pharmaceutical Regulatory Affairs Introduction
11.7.4 ICON Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.7.5 ICON Recent Development
11.8 Charles River
11.8.1 Charles River Company Details
11.8.2 Charles River Business Overview
11.8.3 Charles River Pharmaceutical Regulatory Affairs Introduction
11.8.4 Charles River Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.8.5 Charles River Recent Development
11.9 Advent International
11.9.1 Advent International Company Details
11.9.2 Advent International Business Overview
11.9.3 Advent International Pharmaceutical Regulatory Affairs Introduction
11.9.4 Advent International Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.9.5 Advent International Recent Development
11.10 WuXi AppTec, Inc.
11.10.1 WuXi AppTec, Inc. Company Details
11.10.2 WuXi AppTec, Inc. Business Overview
11.10.3 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Introduction
11.10.4 WuXi AppTec, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.10.5 WuXi AppTec, Inc. Recent Development
11.11 Pharmaron Beijing Co., Ltd.
11.11.1 Pharmaron Beijing Co., Ltd. Company Details
11.11.2 Pharmaron Beijing Co., Ltd. Business Overview
11.11.3 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Introduction
11.11.4 Pharmaron Beijing Co., Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.11.5 Pharmaron Beijing Co., Ltd. Recent Development
11.12 Hangzhou Tigermed Consulting Co.,Ltd.
11.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Company Details
11.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Business Overview
11.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
11.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Recent Development
11.13 Asymchem Laboratories (Tianjin) Co.,Ltd.
11.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Company Details
11.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Business Overview
11.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
11.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Development
11.14 Accell Clinical Research, LLC.
11.14.1 Accell Clinical Research, LLC. Company Details
11.14.2 Accell Clinical Research, LLC. Business Overview
11.14.3 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Introduction
11.14.4 Accell Clinical Research, LLC. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.14.5 Accell Clinical Research, LLC. Recent Development
11.15 GenPact Ltd.
11.15.1 GenPact Ltd. Company Details
11.15.2 GenPact Ltd. Business Overview
11.15.3 GenPact Ltd. Pharmaceutical Regulatory Affairs Introduction
11.15.4 GenPact Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.15.5 GenPact Ltd. Recent Development
11.16 Criterium, Inc.
11.16.1 Criterium, Inc. Company Details
11.16.2 Criterium, Inc. Business Overview
11.16.3 Criterium, Inc. Pharmaceutical Regulatory Affairs Introduction
11.16.4 Criterium, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.16.5 Criterium, Inc. Recent Development
11.17 Promedica International
11.17.1 Promedica International Company Details
11.17.2 Promedica International Business Overview
11.17.3 Promedica International Pharmaceutical Regulatory Affairs Introduction
11.17.4 Promedica International Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.17.5 Promedica International Recent Development
11.18 Medpace
11.18.1 Medpace Company Details
11.18.2 Medpace Business Overview
11.18.3 Medpace Pharmaceutical Regulatory Affairs Introduction
11.18.4 Medpace Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.18.5 Medpace Recent Development
11.18 Covance
.1 Covance Company Details
.2 Covance Business Overview
.3 Covance Pharmaceutical Regulatory Affairs Introduction
.4 Covance Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
.5 Covance Recent Development
11.20 Freyr
11.20.1 Freyr Company Details
11.20.2 Freyr Business Overview
11.20.3 Freyr Pharmaceutical Regulatory Affairs Introduction
11.20.4 Freyr Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.20.5 Freyr Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pharmaceutical Regulatory Affairs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Regulatory Consulting
Table 3. Key Players of Legal Representation
Table 4. Key Players of Regulatory Writing & Publishing
Table 5. Key Players of Product Registration & Clinical Trial Application
Table 6. Key Players of Other Services
Table 7. Global Pharmaceutical Regulatory Affairs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pharmaceutical Regulatory Affairs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pharmaceutical Regulatory Affairs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Pharmaceutical Regulatory Affairs Market Share by Regions (2016-2021)
Table 11. Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Pharmaceutical Regulatory Affairs Market Share by Regions (2022-2027)
Table 13. Pharmaceutical Regulatory Affairs Market Trends
Table 14. Pharmaceutical Regulatory Affairs Market Drivers
Table 15. Pharmaceutical Regulatory Affairs Market Challenges
Table 16. Pharmaceutical Regulatory Affairs Market Restraints
Table 17. Global Pharmaceutical Regulatory Affairs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Pharmaceutical Regulatory Affairs Market Share by Players (2016-2021)
Table 19. Global Top Pharmaceutical Regulatory Affairs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Regulatory Affairs as of 2020)
Table 20. Ranking of Global Top Pharmaceutical Regulatory Affairs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Pharmaceutical Regulatory Affairs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pharmaceutical Regulatory Affairs Product Solution and Service
Table 24. Date of Enter into Pharmaceutical Regulatory Affairs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2016-2021)
Table 28. Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Pharmaceutical Regulatory Affairs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Application (2016-2021)
Table 32. Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027) & (US$ Million)
Table 64. QuintilesIMS Company Details
Table 65. QuintilesIMS Business Overview
Table 66. QuintilesIMS Pharmaceutical Regulatory Affairs Product
Table 67. QuintilesIMS Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 68. QuintilesIMS Recent Development
Table 69. LabCor Company Details
Table 70. LabCor Business Overview
Table 71. LabCor Pharmaceutical Regulatory Affairs Product
Table 72. LabCor Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 73. LabCor Recent Development
Table 74. PAREXEL Company Details
Table 75. PAREXEL Business Overview
Table 76. PAREXEL Pharmaceutical Regulatory Affairs Product
Table 77. PAREXEL Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 78. PAREXEL Recent Development
Table 79. Pharmaceutical Product Development Company Details
Table 80. Pharmaceutical Product Development Business Overview
Table 81. Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Product
Table 82. Pharmaceutical Product Development Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 83. Pharmaceutical Product Development Recent Development
Table 84. INC RESEARCH HOLDINGS Company Details
Table 85. INC RESEARCH HOLDINGS Business Overview
Table 86. INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Product
Table 87. INC RESEARCH HOLDINGS Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 88. INC RESEARCH HOLDINGS Recent Development
Table 89. PRA Health Sciences Company Details
Table 90. PRA Health Sciences Business Overview
Table 91. PRA Health Sciences Pharmaceutical Regulatory Affairs Product
Table 92. PRA Health Sciences Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 93. PRA Health Sciences Recent Development
Table 94. ICON Company Details
Table 95. ICON Business Overview
Table 96. ICON Pharmaceutical Regulatory Affairs Product
Table 97. ICON Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 98. ICON Recent Development
Table 99. Charles River Company Details
Table 100. Charles River Business Overview
Table 101. Charles River Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 102. Charles River Recent Development
Table 103. Advent International Company Details
Table 104. Advent International Business Overview
Table 105. Advent International Pharmaceutical Regulatory Affairs Product
Table 106. Advent International Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 107. Advent International Recent Development
Table 108. WuXi AppTec, Inc. Company Details
Table 109. WuXi AppTec, Inc. Business Overview
Table 110. WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Product
Table 111. WuXi AppTec, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 112. WuXi AppTec, Inc. Recent Development
Table 113. Pharmaron Beijing Co., Ltd. Company Details
Table 114. Pharmaron Beijing Co., Ltd. Business Overview
Table 115. Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Product
Table 116. Pharmaron Beijing Co., Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 117. Pharmaron Beijing Co., Ltd. Recent Development
Table 118. Hangzhou Tigermed Consulting Co.,Ltd. Company Details
Table 119. Hangzhou Tigermed Consulting Co.,Ltd. Business Overview
Table 120. Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Product
Table 121. Hangzhou Tigermed Consulting Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 122. Hangzhou Tigermed Consulting Co.,Ltd. Recent Development
Table 123. Asymchem Laboratories (Tianjin) Co.,Ltd. Company Details
Table 124. Asymchem Laboratories (Tianjin) Co.,Ltd. Business Overview
Table 125. Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Product
Table 126. Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 127. Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Development
Table 128. Accell Clinical Research, LLC. Company Details
Table 129. Accell Clinical Research, LLC. Business Overview
Table 130. Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Product
Table 131. Accell Clinical Research, LLC. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 132. Accell Clinical Research, LLC. Recent Development
Table 133. GenPact Ltd. Company Details
Table 134. GenPact Ltd. Business Overview
Table 135. GenPact Ltd. Pharmaceutical Regulatory Affairs Product
Table 136. GenPact Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 137. GenPact Ltd. Recent Development
Table 138. Criterium, Inc. Company Details
Table 139. Criterium, Inc. Business Overview
Table 140. Criterium, Inc. Pharmaceutical Regulatory Affairs Product
Table 141. Criterium, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 142. Criterium, Inc. Recent Development
Table 143. Promedica International Company Details
Table 144. Promedica International Business Overview
Table 145. Promedica International Pharmaceutical Regulatory Affairs Product
Table 146. Promedica International Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 147. Promedica International Recent Development
Table 148. Medpace Company Details
Table 149. Medpace Business Overview
Table 150. Medpace Pharmaceutical Regulatory Affairs Product
Table 151. Medpace Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 152. Medpace Recent Development
Table 153. Covance Company Details
Table 154. Covance Business Overview
Table 155. Covance Pharmaceutical Regulatory Affairs Product
Table 156. Covance Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 157. Covance Recent Development
Table 158. Freyr Company Details
Table 159. Freyr Business Overview
Table 160. Freyr Pharmaceutical Regulatory Affairs Product
Table 161. Freyr Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 162. Freyr Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Regulatory Affairs Market Share by Type: 2020 VS 2027
Figure 2. Regulatory Consulting Features
Figure 3. Legal Representation Features
Figure 4. Regulatory Writing & Publishing Features
Figure 5. Product Registration & Clinical Trial Application Features
Figure 6. Other Services Features
Figure 7. Global Pharmaceutical Regulatory Affairs Market Share by Application: 2020 VS 2027
Figure 8. In-house Case Studies
Figure 9. Outsourcing Case Studies
Figure 10. Pharmaceutical Regulatory Affairs Report Years Considered
Figure 11. Global Pharmaceutical Regulatory Affairs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pharmaceutical Regulatory Affairs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pharmaceutical Regulatory Affairs Market Share by Regions: 2020 VS 2027
Figure 14. Global Pharmaceutical Regulatory Affairs Market Share by Regions (2022-2027)
Figure 15. Global Pharmaceutical Regulatory Affairs Market Share by Players in 2020
Figure 16. Global Top Pharmaceutical Regulatory Affairs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Regulatory Affairs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Regulatory Affairs Revenue in 2020
Figure 18. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2016-2021)
Figure 19. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2022-2027)
Figure 20. North America Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pharmaceutical Regulatory Affairs Market Share by Type (2016-2027)
Figure 22. North America Pharmaceutical Regulatory Affairs Market Share by Application (2016-2027)
Figure 23. North America Pharmaceutical Regulatory Affairs Market Share by Country (2016-2027)
Figure 24. United States Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pharmaceutical Regulatory Affairs Market Share by Type (2016-2

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs